Skip to main content
SpringerLink
Log in

Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase (DPD) splice site variant: the need for further revision of dose and schedule

  • Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Magnani E, Farnetti E, Nicoli D et al (2013) Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule. Intern Emerg Med 8(5):417–423

    Article  PubMed  Google Scholar 

  2. Swen JJ, Nijenhuis M, de Boer A et al (2011) Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharmacol Ther 89(5):662–673

    Article  CAS  PubMed  Google Scholar 

  3. Caudle KE, Thorn CF, Klein TE et al. (2013) Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther 94(6):640–645

    Google Scholar 

  4. Deenen MJ, Cats A, Sechterberger MK et al. (2011) Safety, pharmacokinetics (PK), and cost-effectiveness of upfront genotyping of PDYD in fluoropyrimidine therapy. J Clin Oncol 29 (suppl abstract 3606)

  5. Terrazzino S, Cargnin S, Del Re M, Danesi R, Canonico PL, Genazzani AA (2013) DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis. Pharmacogenomics 14(11):1255–1272

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands

    Paul Christiaan Dirk Bank, Henk-Jan Guchelaar & Joachim Jesse Swen

Authors
  1. Paul Christiaan Dirk Bank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henk-Jan Guchelaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joachim Jesse Swen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim Jesse Swen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bank, P.C.D., Guchelaar, HJ. & Swen, J.J. Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase (DPD) splice site variant: the need for further revision of dose and schedule. Intern Emerg Med 9, 481–482 (2014). https://doi.org/10.1007/s11739-013-1027-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-013-1027-6

Keywords

Search

Navigation